Our clinical experience with the use of omalizumab in the treatment of bullous pemphigoid

Journal Title: Türkderm - Deri Hastalıkları ve Frengi Arşivi - Year 2017, Vol 51, Issue 4

Abstract

Background and Design: In the era of biological therapies, omalizumab (OMZ), a monoclonal antibody which inhibits IgE, has been postulated to be effective in the treatment of bullous pemphigoid (BP). We report our clinical experience with the use of OMZ in the treatment of BP. Materials and Methods: Retrospective data analyses of eleven patients were performed. Results: Seven patients receiving OMZ treatment demonstrated clinical improvements. Three patients terminated treatment because of intermittent co-morbidities. None of the patients had any significant adverse events. Conclusion: OMZ may be a promising corticosteroid-sparing treatment option for moderate to severe BP patients. Future randomized controlled trials are indicated to evaluate the efficacy of OMZ in the treatment of BP.

Authors and Affiliations

Pınar İncel Uysal, Başak Yalçın, Ayşe Öktem

Keywords

Related Articles

Comparison of Robotic and Laparoscopic Partial Nephrectomy in Robotic Surgery Era

Objective: To compare the results of robotic partial nephrectomy (RPN) and laparoscopic partial nephrectomy (LPN) operations and to determine whether they have any superiority to each other in terms of oncological and fu...

Surgical correction of primary cicatricial alopecia: Experience with nine patients

Background and Design: Primary excision and hair transplantation are infrequently used to treat stable primary cicatricial alopecia (PCA). Follicular unit extraction (FUE) method has gained popularity in recent years. In...

The role of uric acid in metabolic syndrome in patients with psoriasis

Background and Design: Psoriasis patients have increased risk of obesity, metabolic syndrome and cardiovascular disease. Uric acid is a metabolic marker associated with metabolic syndrome and cardiovascular diseases. Uri...

Download PDF file
  • EP ID EP251835
  • DOI 10.4274/turkderm.65983
  • Views 150
  • Downloads 0

How To Cite

Pınar İncel Uysal, Başak Yalçın, Ayşe Öktem (2017). Our clinical experience with the use of omalizumab in the treatment of bullous pemphigoid. Türkderm - Deri Hastalıkları ve Frengi Arşivi, 51(4), 124-128. https://europub.co.uk./articles/-A-251835